Minor Neuropsychological Deficits Indicate Risk for Progression to Alzheimer Disease
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 13, 2023 -- For patients with subjective cognitive decline (SCD), minor neuropsychological deficits (MNPD) are associated with Alzheimer disease-related clinical progression, according to a study published online Oct. 11 in Neurology.
Melina Stark, from the German Center for Neurodegenerative Diseases in Tübingen, and colleagues compared cerebrospinal fluid (CSF) amyloid-β (Aβ)42/Aβ40, phosphorylated tau (p-tau181), total tau, and Aβ42/p-tau181 levels, longitudinal cognitive composite trajectories, and risk for clinical progression to incident mild cognitive impairment (MCI) among patients with SCD with and without MNPD. The analysis included 672 patients: 384 with SCD without MNPD, 55 with SCD with MNPD, and 215 healthy controls.
The researchers found that compared with SCD patients without MNPD, those with MNPD had significantly more abnormal CSF biomarker levels, increased cognitive decline, and increased risk for progression to incident MCI (hazard ratio, 4.07). For progression of SCD to MCI within three years, MNPD had a positive predictive value of 57.0 percent and a negative predictive value of 86.0 percent. Compared with healthy controls without MNPD, SCD patients without MNPD had increased cognitive decline and a higher risk for incident MCI, but these groups had no significant difference in the Alzheimer disease biomarker levels.
"Testing for these deficits in people with self-reported decline could help identify people at a higher risk for progressing to mild cognitive impairment," coauthor Michael Wagner, M.D., also from the German Center for Neurodegenerative Diseases, said in a statement.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181
MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...
Lower Cognitive Function in Adolescence Linked to Stroke Risk
FRIDAY, June 28, 2024 -- Lower cognitive function in adolescence is associated with increased risk of early-onset stroke, according to a study published online June 27 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.